Evidence map›Paper›PMID 33841014›Full record

ArticleJournal of ginseng research2021

Prebiotics enhance the biotransformation and bioavailability of ginsenosides in rats by modulating gut microbiota.

Xiaoyan Zhang, Sha Chen, Feipeng Duan, An Liu, Shaojing Li, Wen Zhong, Wei Sheng, Jun Chen, Jiang Xu, Shuiming Xiao

Open access · goldAbstract read
In one paragraph

Article in Journal of ginseng research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Therapeutic properties of plant-derived prebiotics in melanoma.Exploration of targeted anti-tumor therapy · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Effects of Chenpi (Frontiers in microbiology · 2024
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Ginseng polysaccharides: Potential antitumor agents.Journal of ginseng research · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xiaoyan ZhangInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Sha ChenInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Feipeng DuanInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
An LiuInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Shaojing LiInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Wen ZhongInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Wei ShengCollege of Life Science, Huaibei Normal University, Huaibei, 235000, China.
Jun ChenBig Data and Engineering Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.
Jiang XuInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Shuiming XiaoInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNHuaibei Normal University · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGut microbiota mainly function in the biotransformation of primary ginsenosides into bioactive metabolites. Herein, we investigated the effects of three prebiotic fibers by targeting gut microbiota on the metabolism of ginsenoside Rb1

methodsSprague Dawley rats were administered with ginsenoside Rb1 after a two-week prebiotic intervention of fructooligosaccharide, galactooligosaccharide, and fibersol-2, respectively. Pharmacokinetic analysis of ginsenoside Rb1 and its metabolites was performed, whilst the microbial composition and metabolic function of gut microbiota were examined by 16S rRNA gene amplicon and metagenomic shotgun sequencing.

resultsThe results showed that peak plasma concentration and area under concentration time curve of ginsenoside Rb1 and its intermediate metabolites, ginsenoside Rd, F2, and compound K (CK), in the prebiotic intervention groups were increased at various degrees compared with those in the control group. Gut microbiota dramatically responded to the prebiotic treatment at both taxonomical and functional levels. The abundance of

conclusionThese findings imply that prebiotics may selectively promote the proliferation of certain bacterial stains with glycoside hydrolysis capacity, thereby, subsequently improving the biotransformation and bioavailability of primary ginsenosides

Indexed as

ANOVA, analysis of varianceAUC, area under the concentration-time curveBioavailabilityBiotransformationCAT, CAZymes Analysis ToolkitCAZymes, carbohydrate active enzymesCK, compound KCmax, peak plasma concentrationFDR, false discovery rateFOS, fructooligosaccharideGinsenosideGOS, galactooligosaccharideGut microbiotaIS, internal standardKEGG, the Kyoto Encyclopaedia of Genes and GenomesLCA, lowest common ancestorLDA, linear discriminant analysisLEfSe, LDA effect sizeLLOQs, lower limits of quantificationsMANOVA, multivariate ANOVAMRM, multiple reaction monitoringNMDS, non-metric multidimensional scalingPCA, principal component analysisPCoA, principal coordinates analysisPrebioticSD, Sprague DawleySRA, Sequence Read ArchiveTmax, time of maximum plasma concentrationUPLC-ESI-QqQ-MS/MS, ultra-high pressure liquid chromatography coupled to an electrospray ionization source and a triple-quadrupole mass spectrometer

Identifiers

PMID33841014
PMCPMC8020290
OpenAlexW3047682843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.